Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) - the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

University of Edinburgh spinout Carbogenics, a leading innovator in sustainable biochar technology, is thrilled to announce the successful close of its latest funding round, securing just under half a million pounds. This significant milestone reflects the confidence of both existing and new investors in Carbogenics’ mission to revolutionise sustainable solutions and expand its global footprint.

Aberdeen-based biotechnology company NCIMB is collaborating with the pioneering Rowett Institute to develop a tool that will improve understanding of microbes that have important roles in human health and disease, and support development of new treatments for inflammatory bowel disease, liver disease and cancer. The work has received funding from Innovate UK.

MarinaTex, a pioneer in developing marine-derived biomaterials as alternatives to problematic single-use plastics, has announced the appointment of Craig Sterling as its new Chief Executive Officer (CEO).

Independent Scottish distillery Eden Mill has announced a partnership with leading Scottish biotech company, and Earthshot Prize finalists, MiAlgae, to repurpose whisky effluent, a by-product of distillation, to grow microalgae as a sustainable source of Omega-3s.

MiAlgae, a leader in sustainable food production and marine ecosystem restoration, has been recognised as a finalist for the prestigious 2024 Earthshot Prize.

E.V.A Biosystems has secured the top spot in the SSE-sponsored Net Zero category at the Converge Awards thanks to its groundbreaking ‘smart’ plastic that senses its surroundings and degrades on contact with seawater, offering a microplastic-free solution to the global issue of ocean pollution.

In August, Isomerase, a synthetic biology company who use microbes to make a range of products from therapeutics to enzymes, announced the launch of a powerful new tool designed to enhance the directed evolution of enzymes.

Green Bioactives (GBL), a pioneering world-class company in the discovery, development and sustainable production of high value plant-based products, is delighted to announce that it has been awarded a £100,000 Scottish Enterprise SMART grant.